Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation.

Eriksson O, Chiu J, Hogg PJ, Atkinson JP, Liszewski MK, Flaumenhaft R, Furie B.

J Biol Chem. 2019 Mar 29;294(13):4878-4888. doi: 10.1074/jbc.RA118.006792. Epub 2019 Jan 22.

PMID:
30670593
2.

TMX1: a new vascular thiol isomerase.

Hogg PJ.

Blood. 2019 Jan 17;133(3):188-190. doi: 10.1182/blood-2018-11-887679. No abstract available.

PMID:
30655304
3.

Allosteric disulfides: Sophisticated molecular structures enabling flexible protein regulation.

Chiu J, Hogg PJ.

J Biol Chem. 2019 Feb 22;294(8):2949-2960. doi: 10.1074/jbc.REV118.005604. Epub 2019 Jan 10. Review.

4.

Platelet Protein Disulfide Isomerase Promotes Glycoprotein Ibα-Mediated Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions.

Li J, Kim K, Jeong SY, Chiu J, Xiong B, Petukhov PA, Dai X, Li X, Andrews RK, Du X, Hogg PJ, Cho J.

Circulation. 2019 Mar 5;139(10):1300-1319. doi: 10.1161/CIRCULATIONAHA.118.036323. Erratum in: Circulation. 2019 Mar 5;139(10):e529.

PMID:
30586735
5.

γ-Crystallin redox-detox in the lens.

Quinlan RA, Hogg PJ.

J Biol Chem. 2018 Nov 16;293(46):18010-18011. doi: 10.1074/jbc.H118.006240.

6.

Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.

Bekendam RH, Iyu D, Passam F, Stopa JD, De Ceunynck K, Muse O, Bendapudi PK, Garnier CL, Gopal S, Crescence L, Chiu J, Furie B, Panicot-Dubois L, Hogg PJ, Dubois C, Flaumenhaft R.

J Thromb Haemost. 2018 Nov;16(11):2322-2335. doi: 10.1111/jth.14291. Epub 2018 Oct 12.

PMID:
30207066
7.

Mechano-redox control of integrin de-adhesion.

Passam F, Chiu J, Ju L, Pijning A, Jahan Z, Mor-Cohen R, Yeheskel A, Kolšek K, Thärichen L, Aponte-Santamaría C, Gräter F, Hogg PJ.

Elife. 2018 Jun 22;7. pii: e34843. doi: 10.7554/eLife.34843.

8.

Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.

Pasalic L, Wing-Lun E, Lau JK, Campbell H, Pennings GJ, Lau E, Connor D, Liang HP, Muller D, Kritharides L, Hogg PJ, Chen VM.

J Thromb Haemost. 2018 Jun;16(6):1198-1210. doi: 10.1111/jth.14008. Epub 2018 May 8.

PMID:
29569428
9.

Identification of allosteric disulfides from labile bonds in X-ray structures.

Pijning AE, Chiu J, Yeo RX, Wong JWH, Hogg PJ.

R Soc Open Sci. 2018 Feb 7;5(2):171058. doi: 10.1098/rsos.171058. eCollection 2018 Feb.

10.

Autoregulation of von Willebrand factor function by a disulfide bond switch.

Butera D, Passam F, Ju L, Cook KM, Woon H, Aponte-Santamaría C, Gardiner E, Davis AK, Murphy DA, Bronowska A, Luken BM, Baldauf C, Jackson S, Andrews R, Gräter F, Hogg PJ.

Sci Adv. 2018 Feb 28;4(2):eaaq1477. doi: 10.1126/sciadv.aaq1477. eCollection 2018 Feb.

11.

Direct Polymerization of the Arsenic Drug PENAO to Obtain Nanoparticles with High Thiol-Reactivity and Anti-Cancer Efficiency.

Noy JM, Lu H, Hogg PJ, Yang JL, Stenzel M.

Bioconjug Chem. 2018 Feb 21;29(2):546-558. doi: 10.1021/acs.bioconjchem.8b00032. Epub 2018 Feb 7.

PMID:
29346731
12.

Zinc is a potent and specific inhibitor of IFN-λ3 signalling.

Read SA, O'Connor KS, Suppiah V, Ahlenstiel CLE, Obeid S, Cook KM, Cunningham A, Douglas MW, Hogg PJ, Booth D, George J, Ahlenstiel G.

Nat Commun. 2017 May 17;8:15245. doi: 10.1038/ncomms15245.

13.

One-Way Allosteric Communication between the Two Disulfide Bonds in Tissue Factor.

Zhou B, Hogg PJ, Gräter F.

Biophys J. 2017 Jan 10;112(1):78-86. doi: 10.1016/j.bpj.2016.12.003.

14.

A substrate-driven allosteric switch that enhances PDI catalytic activity.

Bekendam RH, Bendapudi PK, Lin L, Nag PP, Pu J, Kennedy DR, Feldenzer A, Chiu J, Cook KM, Furie B, Huang M, Hogg PJ, Flaumenhaft R.

Nat Commun. 2016 Aug 30;7:12579. doi: 10.1038/ncomms12579.

15.

Necrotic platelets provide a procoagulant surface during thrombosis.

Hua VM, Abeynaike L, Glaros E, Campbell H, Pasalic L, Hogg PJ, Chen VM.

Blood. 2015 Dec 24;126(26):2852-62. doi: 10.1182/blood-2015-08-663005. Epub 2015 Oct 16.

16.

Protein Disulfide Isomerase in Thrombosis.

Chiu J, Passam F, Butera D, Hogg PJ.

Semin Thromb Hemost. 2015 Oct;41(7):765-73. doi: 10.1055/s-0035-1564047. Epub 2015 Sep 26. Review.

PMID:
26408919
17.

Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.

Decollogne S, Joshi S, Chung SA, Luk PP, Yeo RX, Nixdorf S, Fedier A, Heinzelmann-Schwarz V, Hogg PJ, Dilda PJ.

Gynecol Oncol. 2015 Aug;138(2):363-71. doi: 10.1016/j.ygyno.2015.06.018. Epub 2015 Jun 14.

PMID:
26080289
18.

Organic arsenicals as efficient and highly specific linkers for protein/peptide-polymer conjugation.

Wilson P, Anastasaki A, Owen MR, Kempe K, Haddleton DM, Mann SK, Johnston AP, Quinn JF, Whittaker MR, Hogg PJ, Davis TP.

J Am Chem Soc. 2015 Apr 1;137(12):4215-22. doi: 10.1021/jacs.5b01140. Epub 2015 Mar 20.

PMID:
25794267
19.

Dual-targeting of aberrant glucose metabolism in glioblastoma.

Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL.

J Exp Clin Cancer Res. 2015 Feb 5;34:14. doi: 10.1186/s13046-015-0130-0.

20.

Targeting of two aspects of metabolism in breast cancer treatment.

Gang BP, Dilda PJ, Hogg PJ, Blackburn AC.

Cancer Biol Ther. 2014;15(11):1533-41. doi: 10.4161/15384047.2014.955992.

21.

Redox regulation of methionine aminopeptidase 2 activity.

Chiu J, Wong JW, Hogg PJ.

J Biol Chem. 2014 May 23;289(21):15035-43. doi: 10.1074/jbc.M114.554253. Epub 2014 Apr 3.

22.

Employing pancreatic tumor γ-glutamyltransferase for therapeutic delivery.

Ramsay EE, Decollogne S, Joshi S, Corti A, Apte M, Pompella A, Hogg PJ, Dilda PJ.

Mol Pharm. 2014 May 5;11(5):1500-11. doi: 10.1021/mp400664t. Epub 2014 Apr 2.

PMID:
24654974
23.

Control of blood proteins by functional disulfide bonds.

Butera D, Cook KM, Chiu J, Wong JW, Hogg PJ.

Blood. 2014 Mar 27;123(13):2000-7. doi: 10.1182/blood-2014-01-549816. Epub 2014 Feb 12. Review.

24.

Mechanism of dimerization of a recombinant mature vascular endothelial growth factor C.

Chiu J, Wong JW, Gerometta M, Hogg PJ.

Biochemistry. 2014 Jan 14;53(1):7-9. doi: 10.1021/bi401518b. Epub 2013 Dec 26.

PMID:
24354278
25.

Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.

Butera D, Wind T, Lay AJ, Beck J, Castellino FJ, Hogg PJ.

J Biol Chem. 2014 Jan 31;289(5):2992-3000. doi: 10.1074/jbc.M113.539924. Epub 2013 Dec 12.

26.

Allosteric control of βII-tryptase by a redox active disulfide bond.

Cook KM, McNeil HP, Hogg PJ.

J Biol Chem. 2013 Nov 29;288(48):34920-9. doi: 10.1074/jbc.M113.523506. Epub 2013 Oct 18.

27.

Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing.

Dick LJ, Gray A, Ram A, Hume A, Parris C, Hogg PJ, Elliott MA, Ford SJ, Halbert GW.

J Pharm Pharmacol. 2013 Nov;65(11):1664-9. doi: 10.1111/jphp.12143. Epub 2013 Sep 18.

PMID:
24102542
28.

Tyrosine nitration moderates the peptidase activity of human methionyl aminopeptidase 2.

Ng JY, Chiu J, Hogg PJ, Wong JW.

Biochem Biophys Res Commun. 2013 Oct 11;440(1):37-42. doi: 10.1016/j.bbrc.2013.09.035. Epub 2013 Sep 13.

PMID:
24041691
29.

Optical imaging of treatment-related tumor cell death using a heat shock protein-90 alkylator.

Park D, Xie BW, Van Beek ER, Blankevoort V, Que I, Löwik CW, Hogg PJ.

Mol Pharm. 2013 Oct 7;10(10):3882-91. doi: 10.1021/mp4003464. Epub 2013 Sep 10.

PMID:
23968358
30.

Encryption and decryption of tissue factor.

Chen VM, Hogg PJ.

J Thromb Haemost. 2013 Jun;11 Suppl 1:277-84. doi: 10.1111/jth.12228. Review.

31.

Targeting allosteric disulphide bonds in cancer.

Hogg PJ.

Nat Rev Cancer. 2013 Jun;13(6):425-31. doi: 10.1038/nrc3519. Epub 2013 May 10. Review. Erratum in: Nat Rev Cancer. 2013 Jul;13(7):518.

PMID:
23660784
32.

Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator.

Xie BW, Park D, Van Beek ER, Blankevoort V, Orabi Y, Que I, Kaijzel EL, Chan A, Hogg PJ, Löwik CW.

Cell Death Dis. 2013 Jan 24;4:e473. doi: 10.1038/cddis.2012.207.

33.

Post-translational control of protein function by disulfide bond cleavage.

Cook KM, Hogg PJ.

Antioxid Redox Signal. 2013 May 20;18(15):1987-2015. doi: 10.1089/ars.2012.4807. Epub 2013 Feb 15. Review.

PMID:
23198756
34.

The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase.

Park D, Chiu J, Perrone GG, Dilda PJ, Hogg PJ.

Cancer Cell Int. 2012 Mar 26;12(1):11. doi: 10.1186/1475-2867-12-11.

35.

Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trial.

Elliott MA, Ford SJ, Prasad E, Dick LJ, Farmer H, Hogg PJ, Halbert GW.

Int J Pharm. 2012 Apr 15;426(1-2):67-75. doi: 10.1016/j.ijpharm.2012.01.024. Epub 2012 Jan 21.

PMID:
22286018
36.

Mitochondrial metabolism inhibitors for cancer therapy.

Ramsay EE, Hogg PJ, Dilda PJ.

Pharm Res. 2011 Nov;28(11):2731-44. doi: 10.1007/s11095-011-0584-5. Epub 2011 Sep 15. Review.

PMID:
21918915
37.

Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain.

Ganderton T, Wong JW, Schroeder C, Hogg PJ.

Blood. 2011 Nov 10;118(19):5312-8. doi: 10.1182/blood-2011-06-360297. Epub 2011 Sep 12.

38.

Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes.

Scott AJ, O'Dea KP, O'Callaghan D, Williams L, Dokpesi JO, Tatton L, Handy JM, Hogg PJ, Takata M.

J Biol Chem. 2011 Oct 14;286(41):35466-76. doi: 10.1074/jbc.M111.277434. Epub 2011 Aug 24.

39.

Redox properties of the tissue factor Cys186-Cys209 disulfide bond.

Liang HP, Brophy TM, Hogg PJ.

Biochem J. 2011 Aug 1;437(3):455-60. doi: 10.1042/BJ20110718.

PMID:
21595632
40.

Noninvasive imaging of cell death using an Hsp90 ligand.

Park D, Don AS, Massamiri T, Karwa A, Warner B, MacDonald J, Hemenway C, Naik A, Kuan KT, Dilda PJ, Wong JW, Camphausen K, Chinen L, Dyszlewski M, Hogg PJ.

J Am Chem Soc. 2011 Mar 9;133(9):2832-5. doi: 10.1021/ja110226y. Epub 2011 Feb 15.

PMID:
21322555
41.

Hypoxia regulates the production and activity of glucose transporter-1 and indoleamine 2,3-dioxygenase in monocyte-derived endothelial-like cells: possible relevance to infantile haemangioma pathogenesis.

Herbert A, Ng H, Jessup W, Kockx M, Cartland S, Thomas SR, Hogg PJ, Wargon O.

Br J Dermatol. 2011 Feb;164(2):308-15. doi: 10.1111/j.1365-2133.2010.10086.x.

PMID:
21039406
42.

Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.

Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, Giannakopoulos B, Hughes WE, Hogg PJ, Krilis SA.

J Thromb Haemost. 2010 Aug;8(8):1754-62. doi: 10.1111/j.1538-7836.2010.03944.x.

43.

Reduced monomeric CD4 is the preferred receptor for HIV.

Matthias LJ, Azimi I, Tabrett CA, Hogg PJ.

J Biol Chem. 2010 Dec 24;285(52):40793-9. doi: 10.1074/jbc.M110.190579. Epub 2010 Oct 25.

44.

Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.

Azimi I, Matthias LJ, Center RJ, Wong JW, Hogg PJ.

J Biol Chem. 2010 Dec 17;285(51):40072-80. doi: 10.1074/jbc.M110.185371. Epub 2010 Oct 13.

45.

Beta 2 glycoprotein I is a substrate of thiol oxidoreductases.

Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, Giannakopoulos B, Hughes WE, Hogg PJ, Krilis SA.

Blood. 2010 Sep 16;116(11):1995-7. doi: 10.1182/blood-2010-02-271494. No abstract available.

46.

Control of mature protein function by allosteric disulfide bonds.

Azimi I, Wong JW, Hogg PJ.

Antioxid Redox Signal. 2011 Jan 1;14(1):113-26. doi: 10.1089/ars.2010.3620. Epub 2010 Oct 28. Review.

PMID:
20831445
47.

Disulfide bond acquisition through eukaryotic protein evolution.

Wong JW, Ho SY, Hogg PJ.

Mol Biol Evol. 2011 Jan;28(1):327-34. doi: 10.1093/molbev/msq194. Epub 2010 Jul 30.

PMID:
20675408
48.

Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury.

Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, Qi M, Yu P, Yu DM, Hogg PJ, Krilis SA.

Blood. 2010 Sep 16;116(11):1961-70. doi: 10.1182/blood-2009-04-215335. Epub 2010 Jun 15.

49.

Analysis of disulfide bonds in protein structures.

Wong JW, Hogg PJ.

J Thromb Haemost. 2010 Apr 30. [Epub ahead of print] No abstract available.

50.

Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.

Tabrett CA, Harrison CF, Schmidt B, Bellingham SA, Hardy T, Sanejouand YH, Hill AF, Hogg PJ.

Biochem J. 2010 May 13;428(2):169-82. doi: 10.1042/BJ20091635.

PMID:
20337594

Supplemental Content

Support Center